23/10/2026
What exactly are biosimilars – and why do they matter? 🧬
For Global Biosimilars Week, we asked our Specialty team to explain the role biosimilars can play in expanding access to biological medicines and creating value for patients and healthcare systems.
Biosimilars can create competition, support important savings for healthcare systems and open up more treatment options for patients.
With 20 years of biosimilars experience and a growing portfolio across multiple markets, STADA continues to work with strong partners to broaden patient access to biological treatments.
▶️ Watch the video to hear it directly from our Specialty colleagues.
More access. More value.